With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Therapeutic Reactivation of p53 to Overcome Apoptotic Resistance in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD & Kimberly Stegmaier, MD||Reach Grants||2015||Massachusetts|
|Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1||Northwestern University (Illinois) / Zibo Zhao, PhD||Young Investigator Grants||2018||Illinois|
|Therapeutic Targeting of LARG-RhoA Signaling Axis in Childhood Leukemia||Cincinnati Children's Hospital Medical Center / Yi Zheng, PhD||Innovation Grants||2013||Ohio|
|Therapeutic Targeting of PGBD5-induced DNA Repair Dependency in Pediatric Solid Tumors||Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD||Reach Grants||2017||New York|
|Therapeutic Targeting of the Disrupted Metabolic State in DIPG||University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD||Innovation Grants||2019||Michigan|
|Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors||University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD||Young Investigator Grants||2019||Ontario|
|Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers||Dana-Farber Cancer Institute / Charles Roberts, MD, PhD||Innovation Grants||2013||Massachusetts|
|Therapeutics In Ovo||Oregon Health & Science University / Charles Keller||Innovation Grants||2008||Oregon|
|Therapies for SHH-subtype Medulloblastoma||Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|TLE1 Tumor Suppressor as a Key Regulator of myc Induced Leukemia||Massachusetts General Hospital / Selvi Ramasamy||Young Investigator Grants||2010||Massachusetts|